Research Studies

CATARACT STUDIES:
 
 Alcon C-11-020
A Multicenter, Prospective, Single Arm, Non-Randomized unmasked, post approval study of the AcrySof® IQ Toric Intraocular Lens Models SN6AT6 - SN6AT9
Participating Physicians: Kevin Y. Jong, MD, John Lim, MD
Study Coordinators: Norma Delbosque,COA (832) 280-3635, Santa Montelongo,CCRC (832) 553-7133
 Baush & Lomb 670
A Randomized, Multicenter, Double-Masked, Parallel-Group Study Assessing the Safety and Efficacy of Loteprednol Etabonate Opthalmic Gel, 0.5% versus Prednisolone Acetate Opthalmic Suspension, 1% for the Treatment of Intraocular Inflammation Following Surgery for Childhood Cataract. 
Participating Physicians: Carlos A. Gonzales, M.D. 
Study Coordinator: Yvette Degley, CCRC 832-553-7100
 Alcon C-12-067
Randomized, Double-Masked, Vehicle Controlled, Clinical Evaluation To Assess The Safety And Efficacy Of Nepafenac Opthalmic Suspension, 0.3% For Improvement In Clinical Outcomes Among Diabetic Subjects Following Cataract Surgery
Participating Physicians: Kevin Y. Jong, MD, John Lim, MD,
W. Colby Stewart M.D., F.A.C.S.
Study Coordinators: Santa Montelongo, CCRC (832) 553-7133, Norma Delbosque,COA (832) 280-3635

GLAUCOMA STUDIES: 
  

 
Bausch & Lomb 769
A Randomized, Multicenter, Double-Masked, Parallel-Group Study Comparing the Safety and Efficacy of BOL-303259-X 0.024% (Latanoprostene Bunod) Ophthalmic Solution With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Open-Angle Glaucoma or Ocular Hypertension – APOLLO Study
Participating Physicians:Richard Ou, MD, John Lim, MD, Justus Thomas, MD
Study Coordinator: Kristi Gilliam (832) 553-7140
Bausch and Lomb 770
A Randomized, Multicenter, Double-Masked, Parallel-Group Study Comparing the Safety and Efficacy of BOL-303259-X 0.024% (Latanoprostene Bunod) Ophthalmic Solution With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Open-Angle Glaucoma or Ocular Hypertension – LUNAR Study
Participating Physicians:
Fiaz Zaman, MD,  Jeffrey B. Arnoult, MD
Study Coordinators: Santa Montelongo (832) 553-7133, Norma Delbosque (832) 280-3635
 
Alcon M-13-020
Additive Effect of Brinzolamide 1% / Brimonidine 0.2% Fixed Dose Combination as Adjunctive Therapy to a Prostaglandin Analogue
Study Coordinator:  Caroline Beard (832) 553-7140

UVEITIS STUDIES:

 
  Abbott Protocol M10-877
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Participating Physicians: Susan Wittenberg, MD, Bailey L. Lee MD, Kelly L. Larkin, MD
Study Coordinators: Yvette Degley, CCRC (832) 553-7100
 
  Abbott Protocol M10-880
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects with Inactive Non-Infectious Intermediate-Posterior-, or Pan-uveitis
Participating Physicians: Susan Wittenberg, MD, Bailey L. Lee MD, Kelly L. Larkin, MD
Study Coordinators: Yvette Degley, CCRC (832) 553-7100
 
  Abbott Protocol M11-327
A Multicenter Open-Label Study of the Long-term Safety and Efficacy of the human Anti-TNF Monoclonal Antibody Adalimumab in Subjects with Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Participating Physicians: Susan Wittenberg, MD, Bailey L. Lee MD, Kelly L. Larkin, MD
Study Coordinators: Yvette Degley, CCRC (832) 553-7100, Maira Ansari, BS (832) 553-7160
   Xoma X052130 The EYEGUARD™ - A Study
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan-Uveitis
Participating Physicians: Susan Wittenberg, MDKelly L. Larkin, MD
Study Coordinator: Yvette Degley, CCRC(832) 553-7100  
 Xoma X052131 The EYEGUARD™ - C Study
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects with  Non-infectious Intermediate, Posterior, or Pan-Uveitis Currently Controlled with Systemic Treatment
Participating Physicians: Susan Wittenberg, MD, Kelly L. Larkin, MD
Study Coordinator: Yvette Degley, CCRC (832) 553-7100
 
SEVERE VERNAL KERATOCONJUNCTIVITIS STUDY:
Nova22007
A Multicenter, Randomized, Double-Masked, 3 Parallel Arms, Placebo Controlled Study to Assess the Efficacy and Safety of NOVA22007 1mg/mL (Ciclosporin/Cyclosporine) eye drops, Emulsion Administered in Paediatric Patients with Active Severe Vernal Keratoconjunctivitis with Severe Keratitis
Participating Physicians:
Mark C. Vital, MD, Jeffrey D. Lanier, MD,Carlos A. Gonzales, MD
Study Coordinator: Yvette Degley, CCRC (832)553-7100

DIABETIC MACULAR EDEMA STUDY:
Ampio AP-05-002
A Randomzied, Placebo-Controlled, Parallel, Double-Masked Study to Evaluate the Efficacy and Safety of Two Doses of Oral Optina In Adult Patients with Diabetic Macular Edema
Participating Physicians: Lindsey Harris M.D., F.A.C.S., Michael Bloome M.D., F.A.C.S.,
Paul Salmonsen M.D., F.A.C.S., Carolyn Chen M.D.,Andrew C. Kopel M.D., Bailey Lee M.D.
Study Coordinator: Yvette Degley, CCRC (832) 553-7100

Amblyopia Studies:

  PEDIG ATS 17 - ENROLLMENT CLOSED
A Randomized Trial of Levodopa as Treatment for Residual Amblyopia
Participating Physician: Aaron M. Miller, MD
Study Coordinator: Jorie Jackson, CO (832) 553-7177

Strabismus Studies:

  PEDIG IXT 1
A Randomized Trial of Bilateral Lateral Rectus Recession versus Unilateral Lateral Rectus Recession with Medial Rectus Resection for Intermittent Exotropia
Participating Physician: Aaron M. Miller, MD
Study Coordinator: Jorie Jackson, CO (832) 553-7177
 
 HTS 1
Glasses versus observation for moderate hyperopia in young children.

Participating Physician: Aaron M. Miller, MD
Study Coordinator:
Jorie Jackson, CO (832) 553-7177